Physician profile
Shayan Khalafi
NPI 1225560824
$1,709.31
in general payments reported to CMS, 2019-2025
10 companies · $1,686 in 2025
The $1,686 reported for 2025 was more than what 80% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $23.19 · 2025: $1,686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $859 · Food and Beverage: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $858.74 |
| Food and Beverage | $850.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,189.46 | 2025 | Interstim |
| Olympus Corporation of The Americas | $130.67 | 2025 | Evis Exera III Colonovideoscope |
| Polynovo North America LLC | $125.40 | 2025 | Novosorb Btm |
| Ethicon US, LLC | $110.15 | 2025 | Echelon; Endopath |
| Endo USA, INC. | $37.15 | 2025 | Xiaflex |
| Intuitive Surgical, INC. | $28.98 | 2025 | |
| Innovation Technologies INC | $23.93 | 2025 | Irrisept |
| Aimmune Therapeutics, INC. | $23.40 | 2025 | Vowst |
| Stryker Corporation | $23.19 | 2024 | 1788 |
| Abbvie INC. | $16.98 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shayan Khalafi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.